Alpha-1 antitrypsin dysfunction and large artery stroke.
作者信息
Meschia James F
机构信息
Department of Neurology, Mayo Clinic, Jacksonville, FL 32224
出版信息
Proc Natl Acad Sci U S A. 2017 Apr 4;114(14):3555-3557. doi: 10.1073/pnas.1702751114. Epub 2017 Mar 27.
Abstract
摘要
相似文献
1
Alpha-1 antitrypsin dysfunction and large artery stroke.α-1抗胰蛋白酶功能障碍与大动脉性卒中
Proc Natl Acad Sci U S A. 2017 Apr 4;114(14):3555-3557. doi: 10.1073/pnas.1702751114. Epub 2017 Mar 27.
2
Key current clinical issues in alpha-1 antitrypsin deficiency.α-1抗胰蛋白酶缺乏症当前的关键临床问题。
Respir Care. 2003 Dec;48(12):1216-21; discussion 1221-4.
3
Giant intracranial aneurysm and fibromuscular dysplasia in an adolescent with alpha 1-antitrypsin deficiency.一名患有α1-抗胰蛋白酶缺乏症的青少年出现巨大颅内动脉瘤和纤维肌发育不良。
J Neurosurg. 1996 Sep;85(3):503-6. doi: 10.3171/jns.1996.85.3.0503.
4
Compelling evidence for the efficacy of α1-antitrypsin augmentation treatment for α1-antitrypsin deficiency.α1抗胰蛋白酶替代治疗对α1抗胰蛋白酶缺乏症疗效的确凿证据。
Lancet Respir Med. 2017 Jan;5(1):7-8. doi: 10.1016/S2213-2600(16)30434-9. Epub 2016 Dec 2.
5
[Alpha-1 antitrypsin deficiency. A diagnostic approach and case report].
Minerva Pediatr. 1995 Jan-Feb;47(1-2):27-31.
6
Alpha-1-antitrypsin deficiency and liver disease.α-1抗胰蛋白酶缺乏症与肝脏疾病
Dig Dis. 1994 May-Jun;12(3):139-49. doi: 10.1159/000171447.
7
[Alpha 1 antitrypsin deficiency and liver diseases].[α1抗胰蛋白酶缺乏症与肝脏疾病]
Sem Hop. 1975 Mar 26;51(15):1019-24.
8
Anti-Proteases and Alpha-1 Antitrypsin Augmentation Therapy.抗蛋白酶与α-1抗胰蛋白酶补充疗法
Respir Care. 2018 Jun;63(6):690-698. doi: 10.4187/respcare.05933.
9
Alpha-1 antitrypsin deficiency: Pathophysiologic features and the importance of screening.α-1抗胰蛋白酶缺乏症：病理生理特征及筛查的重要性。
JAAPA. 2016 Dec;29(12):1-3. doi: 10.1097/01.JAA.0000502862.36222.ec.
10
[Panniculitis associated with severe alpha 1-antitrypsin deficiency].[与严重α1-抗胰蛋白酶缺乏相关的脂膜炎]
Ugeskr Laeger. 1994 Mar 7;156(10):1474-5.
引用本文的文献
1
Serpin family proteins as potential biomarkers and therapeutic drugs in stroke: A systematic review and meta-analysis on clinical/preclinical studies.丝氨酸蛋白酶抑制剂家族蛋白作为脑卒中的潜在生物标志物和治疗药物：临床/临床前研究的系统评价和荟萃分析。
CNS Neurosci Ther. 2023 Jul;29(7):1738-1749. doi: 10.1111/cns.14205. Epub 2023 Apr 5.
2
Circulating exosomal lncRNAs as predictors of risk and unfavorable prognosis for large artery atherosclerotic stroke.循环外泌体长链非编码RNA作为大动脉粥样硬化性卒中风险和不良预后的预测指标
Clin Transl Med. 2021 Dec;11(12):e555. doi: 10.1002/ctm2.555.
3
Serum Proteome Alterations in Human Cystathionine β-Synthase Deficiency and Ischemic Stroke Subtypes.胱硫醚-β-合酶缺乏症和缺血性脑卒中亚型患者血清蛋白质组的变化。
Int J Mol Sci. 2019 Jun 25;20(12):3096. doi: 10.3390/ijms20123096.
4
Friend or Foe: A Cancer Suppressor MicroRNA-34 Potentially Plays an Adverse Role in Vascular Diseases by Regulating Cell Apoptosis and Extracellular Matrix Degradation.敌友难辨：抑癌 microRNA-34 通过调控细胞凋亡和细胞外基质降解，可能在血管疾病中发挥不利作用。
Med Sci Monit. 2019 Mar 15;25:1952-1959. doi: 10.12659/MSM.915270.
本文引用的文献
1
Common coding variant in increases the risk for large artery stroke.常见编码变异使大动脉中风风险增加。
Proc Natl Acad Sci U S A. 2017 Apr 4;114(14):3613-3618. doi: 10.1073/pnas.1616301114. Epub 2017 Mar 6.
2
Trans-ethnic study design approaches for fine-mapping.用于精细定位的跨种族研究设计方法。
Eur J Hum Genet. 2016 Aug;24(9):1330-6. doi: 10.1038/ejhg.2016.1. Epub 2016 Feb 3.
3
Genome-Wide Association Study of Peripheral Arterial Disease in a Japanese Population.日本人群外周动脉疾病的全基因组关联研究。
PLoS One. 2015 Oct 21;10(10):e0139262. doi: 10.1371/journal.pone.0139262. eCollection 2015.
4
Challenges and Prospects for Alpha-1 Antitrypsin Deficiency Gene Therapy.α-1抗胰蛋白酶缺乏症基因治疗的挑战与前景
Hum Gene Ther. 2015 Nov;26(11):709-18. doi: 10.1089/hum.2015.044. Epub 2015 Sep 29.
5
Magnetic resonance angiography detection of abnormal carotid artery plaque in patients with cryptogenic stroke.磁共振血管造影术检测隐源性卒中患者的异常颈动脉斑块
J Am Heart Assoc. 2015 Jun 15;4(6):e002012. doi: 10.1161/JAHA.115.002012.
6
Agreement between TOAST and CCS ischemic stroke classification: the NINDS SiGN study.TOAST与CCS缺血性卒中分类之间的一致性：美国国立神经疾病与中风研究所（NINDS）的SiGN研究
Neurology. 2014 Oct 28;83(18):1653-60. doi: 10.1212/WNL.0000000000000942. Epub 2014 Sep 26.
7
Screening for asymptomatic carotid artery stenosis: a systematic review and meta-analysis for the U.S. Preventive Services Task Force.无症状性颈动脉狭窄筛查：美国预防服务工作组的系统评价和荟萃分析。
Ann Intern Med. 2014 Sep 2;161(5):336-46. doi: 10.7326/M14-0530.
8
Shared genetic susceptibility to ischemic stroke and coronary artery disease: a genome-wide analysis of common variants.缺血性中风和冠状动脉疾病的共同遗传易感性：常见变异的全基因组分析。
Stroke. 2014 Jan;45(1):24-36. doi: 10.1161/STROKEAHA.113.002707. Epub 2013 Nov 21.
9
HDAC9 gene is associated with stroke risk in a Chinese population.HDAC9 基因与中国人群的中风风险相关。
Exp Biol Med (Maywood). 2013 Jul;238(7):842-7. doi: 10.1177/1535370213494650. Epub 2013 Jul 4.
10
Evidence HDAC9 genetic variant associated with ischemic stroke increases risk via promoting carotid atherosclerosis.证据表明，与缺血性脑卒中相关的 HDAC9 遗传变异通过促进颈动脉粥样硬化增加了风险。
Stroke. 2013 May;44(5):1220-5. doi: 10.1161/STROKEAHA.111.000217. Epub 2013 Feb 28.
Zotero 插件